Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04568733
Other study ID # 2020-GOKAE-0133
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 30, 2020
Est. completion date December 5, 2020

Study information

Verified date March 2022
Source Izmir Katip Celebi University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Low cardiorespiratory fitness is related cardiovascular and total mortality. In addition, disease risk is increased with low cardiorespiratory fitness. There is strong evidence that physical activity and cardiorespiratory fitness are associated with health variables in healthy individuals. Pilates exercises, which are the subgroups of physical activity, has become popular in recent years. Current evidence suggests that Pilates training improves body composition, respiratory muscle strength, exercise performance and quality of life. In addition to these benefits, recent evidence suggests that Pilates training can improve cardiorespiratory fitness. However, there is lack of evidence on whether practicing Pilates exercises satisfy recommendations for intensity of physical activity which improves and maintains health and cardiovascular fitness. The primary aim of this study is to evaluate the cardiorespiratory responses during a Pilates training session, by measuring cardiorespiratory fitness through oxygen consumption and energy expenditure. The secondary aim of this study is to compare the cardiorespiratory responses during Pilates training session and treadmill walking at different speeds (3.2 kmh and 4.8 kmh). First, resting metabolic rate will be measured. Then, the participants will be randomized to one of the two possible experimental conditions: (1) Pilates training session than treadmill walking or (2) treadmill walking than Pilates training session. Pilates session will consist of warm-up exercises (e.g. breathing, arm circle, cat and camel spinal rotation etc.) and basic mat exercises (e.g. one leg stretching, double leg stretching, the hundred, saw, rolling like a ball, swimming, pelvic curl etc.). The Pilates session will be presented to the participants via recorded video. Participants will walk on treadmill at two different speeds: 3.2 kph (2 mph) and 4.8 kph (3 mph). Participants initially will walk at pace of 3.2 kph for 10 minutes. After 30-40 minutes- rest (after returning baseline values), participants will walk on at pace of 4.8 kph for 10 minutes.


Recruitment information / eligibility

Status Completed
Enrollment 31
Est. completion date December 5, 2020
Est. primary completion date December 5, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - Being healthy (not having any known chronic disease) - Volunteer to participate in the study. Exclusion Criteria: - Pregnancy - Previous disorder/surgery history that can alter physical performance in walking or Pilates session.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Pilates exercise session
The Pilates session will consist of warm-up exercises (e.g. breathing, arm circle, cat and camel spinal rotation etc.) and basic mat exercises (e.g. one leg stretching, double leg stretching, the hundred, saw, rolling like a ball, swimming, pelvic curl etc.). The Pilates session will be presented to the participants via pre-recorded video.
Treadmill walking at 3.2 kph
Participants will walk on a treadmill at 3.2 kph (2 mph) speed for 10 minutes.
Treadmill walking at 4.8 kph
Participants will walk on a treadmill at 4.8 kph (2 mph) speed for 10 minutes.

Locations

Country Name City State
Turkey Izmir Katip Celebi University Izmir

Sponsors (1)

Lead Sponsor Collaborator
Izmir Katip Celebi University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Oxygen Consumption (VO2) Cardiopulmonary exercise testing system will be used to oxygen consumption (L/kg/min) assessments. Oxygen consumption is an indicator of aerobic capacity. Higher scores indicate higher aerobic capacity. The mean of oxygen consumption will be recorded for resting state, Pilates session, treadmill walking at 3.2 kph speed, and treadmill walking at 4.8 kph. Through basal metabolic rate assessment completion (20 minutes), through Pilates session completion (45 minutes), through treadmill walking at 3.2 kph speed completion (10 minutes), through treadmill walking at 4.8 kph speed completion (10 minutes).
Primary Energy Expenditure A cardiopulmonary exercise testing system will be used to assess energy expenditure (kcal/min). Higher scores indicate higher energy expenditure. The mean of energy expenditure will be recorded for resting state, Pilates session, treadmill walking at 3.2 kph speed, and treadmill walking at 4.8 kph. Through basal metabolic rate assessment completion (20 minutes), through Pilates session completion (45 minutes), through treadmill walking at 3.2 kph speed completion (10 minutes), through treadmill walking at 4.8 kph speed completion (10 minutes).
Primary Metabolic Equivalent of Task (MET) Metabolic Equivalent of Task (MET) defines the expression of the intensity of physical activity. 1 MET is the rate of energy expenditure while at rest, set by convention at 3.5 mL of oxygen per kilogram per minute (mL.kg.min-1). A cardiopulmonary exercise testing system will be used to assess the MET values. Higher scores indicate higher exercise intensity. The mean of MET will be recorded for resting state, Pilates session, treadmill walking at 3.2 kph speed, and treadmill walking at 4.8 kph. Through basal metabolic rate assessment completion (20 minutes), through Pilates session completion (45 minutes), through treadmill walking at 3.2 kph speed completion (10 minutes), through treadmill walking at 4.8 kph speed completion (10 minutes).
Secondary Heart Rate Heart rate (beats.min-1) will be assessed using a heart rate monitor. The chest strap will be secured to participants against their skin below the sternum. Higher scores indicate higher heart rate. The mean of heart rate will be recorded for resting state, Pilates session, treadmill walking at 3.2 kph speed, and treadmill walking at 4.8 kph. Through basal metabolic rate assessment completion (20 minutes), through Pilates session completion (45 minutes), through treadmill walking at 3.2 kph speed completion (10 minutes), through treadmill walking at 4.8 kph speed completion (10 minutes).
Secondary Maximum Heart Rate (%MHR) Maximum Heart Rate (%MHR) will be assessed using a heart rate monitor. Heart rate data will be multiplied by 100 and divided by the predicted maximum heart rate to determine the percentage of maximum predicted heart rate (%MHR) achieved by each individual. Higher scores indicate higher exercise intensity. The mean of %MHR will be recorded for resting state, Pilates session, treadmill walking at 3.2 kph speed, and treadmill walking at 4.8 kph. Through basal metabolic rate assessment completion (20 minutes), through Pilates session completion (45 minutes), through treadmill walking at 3.2 kph speed completion (10 minutes), through treadmill walking at 4.8 kph speed completion (10 minutes).
Secondary The International Physical Activity Questionnaires (IPAQ) - short form The International Physical Activity Questionnaires (IPAQ) - short form will be used to inquire about the physical activity levels of the participants. This questionnaire consists of seven questions asking participants to remind the last week's physical activity. The IPAQ-short form inquiries about the number of days and amount of the spent walking, sitting or participating in moderate (e.g., bicycling at a regular pace) and vigorous-intensity activities (e.g., fast bicycling, digging) and reports the frequency and duration of these activity. Higher scores indicate higher levels of physical activity. At baseline
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1